Services
Trademarks
Protect your brand today
Register your Trademark
Post Filing Services
Trademark Protection
Patents
File a patent today
Start a Patent Application
Copyrights
Safeguard your creative ideas
Start a Copyright Application
Business
Incorporate your business today
Start a Business
Legal Forms for Business
Resources
Guest
Live/Pending
NON-FINAL ACTION - MAILED
NON-FINAL ACTION - MAILED
final action
on 13 Nov 2024
Last Applicant/ Owned by
Montréal QC H3A 1T8
CA
Serial Number
79396137 filed on 16th Apr 2024
Registration Number
N/A
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
EGRIFTA 7
Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain injury.
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain injury.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79396137
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Nov 2024 | REFUSAL PROCESSED BY MPU |
| 13th Nov 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 07th Nov 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 06th Nov 2024 | NON-FINAL ACTION WRITTEN |
| 29th Oct 2024 | ASSIGNED TO EXAMINER |
| 29th May 2024 | APPLICATION FILING RECEIPT MAILED |
| 29th May 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 23rd May 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |